Skip to main content
HairCited

Current Treatment of Alopecia Areata.

Maria K Hordinsky
Other The journal of investigative dermatology. Symposium proceedings 2020 3 citações
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D33099380'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Tipo de Estudo
Other
População
None
Intervenção
Current Treatment of Alopecia Areata. None
Comparador
None
Desfecho Primário
None
Direção do Efeito
Mixed
Risco de Viés
Unclear

Abstract

The number of alopecia areata (AA) clinical trials with Jak inhibitors of cytoplasmic tyrosine kinases, including Jak1, Jak2, Jak3, and tyrosine-protein kinase has increased significantly since the last Research Summit. This fact means that the conversation about current treatments for AA now also needs to include a discussion of traditionally used off-label therapies as well as evolving therapies as with Jak inhibitors.

Resumo Rápido

The number of alopecia areata clinical trials with Jak inhibitors of cytoplasmic tyrosine kinases has increased significantly since the last Research Summit, which means that the conversation about current treatments for AA now also needs to include a discussion of traditionally used off-label therapies.

Used In Evidence Reviews

Similar Papers